[go: up one dir, main page]

IL135509A0 - 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of a estrogen deprivation syndrome - Google Patents

2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of a estrogen deprivation syndrome

Info

Publication number
IL135509A0
IL135509A0 IL13550998A IL13550998A IL135509A0 IL 135509 A0 IL135509 A0 IL 135509A0 IL 13550998 A IL13550998 A IL 13550998A IL 13550998 A IL13550998 A IL 13550998A IL 135509 A0 IL135509 A0 IL 135509A0
Authority
IL
Israel
Prior art keywords
aroylbenzo
aryl
treatment
estrogen deprivation
deprivation syndrome
Prior art date
Application number
IL13550998A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL135509A0 publication Critical patent/IL135509A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13550998A 1997-11-14 1998-11-09 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of a estrogen deprivation syndrome IL135509A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6585297P 1997-11-14 1997-11-14
PCT/US1998/023712 WO1999025706A1 (en) 1997-11-14 1998-11-09 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome

Publications (1)

Publication Number Publication Date
IL135509A0 true IL135509A0 (en) 2001-05-20

Family

ID=22065569

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13550998A IL135509A0 (en) 1997-11-14 1998-11-09 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of a estrogen deprivation syndrome

Country Status (21)

Country Link
US (2) US6156786A (pt)
EP (1) EP0920863B1 (pt)
JP (1) JP2001523675A (pt)
KR (1) KR20010031904A (pt)
CN (1) CN1278812A (pt)
AT (1) ATE244565T1 (pt)
AU (1) AU748394B2 (pt)
BR (1) BR9812780A (pt)
CA (1) CA2309824A1 (pt)
DE (1) DE69816244D1 (pt)
EA (1) EA200000520A1 (pt)
HR (1) HRP20000287A2 (pt)
HU (1) HUP0004413A3 (pt)
ID (1) ID24978A (pt)
IL (1) IL135509A0 (pt)
NO (1) NO20002370L (pt)
NZ (1) NZ503990A (pt)
PL (1) PL340432A1 (pt)
TR (1) TR200001290T2 (pt)
WO (1) WO1999025706A1 (pt)
ZA (1) ZA9810215B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
US6096781A (en) 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
US6258826B1 (en) 1998-10-13 2001-07-10 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
WO2011132194A1 (en) * 2010-04-19 2011-10-27 Hetero Research Foundation Process for the preparation of raloxifene hydrochloride
EP2912033A4 (en) 2012-10-24 2016-09-14 Univ Illinois COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-MEDIATED ILLNESSES
CA2928173C (en) 2012-10-24 2021-10-19 The Board Of Trustees Of The University Of Illinois Compositions comprising benzothiophene derivatives and use thereof for treatment of estrogen-related medical disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
JP3989569B2 (ja) * 1995-02-28 2007-10-10 イーライ リリー アンド カンパニー ベンゾチオフェン化合物、中間体、組成物および方法
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5514703A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophene compounds useful for inhibiting lipoxygenase
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
ATE198477T1 (de) * 1995-06-26 2001-01-15 Lilly Co Eli Benzothiophenderivate
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN

Also Published As

Publication number Publication date
NZ503990A (en) 2002-05-31
ZA9810215B (en) 2000-05-09
JP2001523675A (ja) 2001-11-27
KR20010031904A (ko) 2001-04-16
HUP0004413A2 (hu) 2001-08-28
DE69816244D1 (de) 2003-08-14
AU1385899A (en) 1999-06-07
WO1999025706A1 (en) 1999-05-27
BR9812780A (pt) 2000-10-03
NO20002370L (no) 2000-07-05
PL340432A1 (en) 2001-02-12
AU748394B2 (en) 2002-06-06
US6403615B1 (en) 2002-06-11
NO20002370D0 (no) 2000-05-05
TR200001290T2 (tr) 2000-09-21
US6156786A (en) 2000-12-05
ATE244565T1 (de) 2003-07-15
CN1278812A (zh) 2001-01-03
ID24978A (id) 2000-08-31
HRP20000287A2 (en) 2000-08-31
EP0920863A1 (en) 1999-06-09
HUP0004413A3 (en) 2002-12-28
EA200000520A1 (ru) 2000-10-30
CA2309824A1 (en) 1999-05-27
EP0920863B1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
IL145633A0 (en) Pharmaceutical compounds
GB9722520D0 (en) Compounds
AU2935200A (en) Compounds for the treatment of obesity
SI1535613T1 (sl) Postopek za pripravo polimorfne oblike atorvastatin kalcija
NZ270460A (en) Use of piperidine-substituted benzothiophene derivatives for inhibiting bone loss/resorption or for lowering serum cholesterol
IL135509A0 (en) 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of a estrogen deprivation syndrome
IL143949A0 (en) Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
AU3744397A (en) Total synthesis of antitumor acylfulvenes
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
GR3030718T3 (en) Novel prostaglandin analogue.
EP1493741A3 (en) Benzo[b]thiophene compounds, intermediates, processes, compositions and methods
IL161275A (en) [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl] -acid derivatives for the treatment of pain
HU9501466D0 (en) Glycopyranoside benzothiophenes
ATE245637T1 (de) Benzothiophenverbindungen, zubereitungen und verfahren
ATE248830T1 (de) Substituierte 2,3-aryl-benzothiophene und ihre östrogene aktivität
PT832883E (pt) Compostos de tetrahidrobenzo(a)fluoreno e metodos de uso
DE69711528D1 (de) Naphthofluorenverbindungen, Zwischenverbindungen, Zusammensetzungen und Verfahren
IL139770A0 (en) Process for reducing the amount of nitrification-inhibiting sulfur compounds
SI0987268T1 (en) Pharmaceutical agents containing epothilone A-N-oxide and/or epothilone B-N-oxide
HK1036275A (en) Spla 2 inhibitor compounds for treatment of disease
SI1068184T1 (en) N-aryloxyethylamine derivatives for the treatment of depression
IL124878A0 (en) Composition for the treatment of seborrhea